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Summary 
The relation between antineuramini-
dase antibody (A.N.) and natural in-
fluenza infection in 1968 was investigated in the
community of Tecumseh, Michigan. The outbreak
was caused by Hong Kong influenza virus, which
contained a new h&aelig;magglutinin antigen (H3), while
the neuraminidase antigen (N2) was more closely
related to that of Asian viruses circulating since 1957.
In the study group of two hundred and seventy-four
randomly selected adults (aged 20-45), titres of N2
neuraminidase antibody were detected in a hundred
and fifteen (42%) serum samples collected before the
outbreak. Influenza infection during the course of the
outbreak was identified serologically. The frequency
of infection decreased significantly at increasing levels
of pre-existing A.N. antibody. In those subjects who
were not protected from infection, A.N. antibody signifi-
cantly suppressed the clinical expression of infection.
It is concluded that antibody against the neuraminidase
of the influenza virus prevented or modified infection
in a situation in which h&aelig;magglutinin antibody had
no effect.
Introduction
IMMUNE resistance to influenza is related to circu-
lating antibody as determined by the haemagglutina-
tion-inhibition (H.I.) test. 1 Antibody so measured is
now known to be directed mainly against the hxmag-
glutinin 2-one of two surface glycoprotein antigens
of the influenza virion. Antibody can also be elicited
by neuraminidase, the second surface antigen,3 but
tests for its measurement have only become available
in recent years. Thus, the role of antineuraminidase
(A.N.) antibody in infections of man has not been estab-
lished. Possibly A.N. may modify the clinical expression
of influenza infection or, alternatively, may even com-
pletely prevent infection. 5
All studies on the effect of A.N. antibody have been
conducted in the laboratory or in volunteers arti-
ficially challenged with laboratory-grown virus. 4-9
The role of A.N. antibody in natural infection is un-
known. The major problem in such an investigation
is that between major shifts of antigen, influenza
strains all possess similar haemagglutinin and neur-
aminidase antigens and the effect of each antigen
cannot be separately identified. However, in 1968, the
Hong Kong variant of type-A influenza appeared with
a new hxmagglutinin subtype (H3) but with a neur-
aminidase (N2) of similar subtype to that of the pre-
vious Asian strains (H2N2).lO,ll Therefore, individuals
in 1968 could possess pre-existing A.N. antibodies
to the Hong Kong strain in the absence of haemag-
glutinin antibodies. During this period a prospective
study of respiratory infections was under way in the
community of Tecumseh, Michigan, and the present
report describes the effect of pre-existing neuramini-
dase antibodies on illness and infection during the
1968 outbreak of Hong Kong influenza.
Methods
Population
The study of respiratory illness in Tecumseh has been
described in detail elsewhere.12 Families in which the
parents were under 45 years of age were randomly selected.
Surveillance of these families was started on a staggered
basis, and thereafter families were contacted at weekly
intervals for 1 year to determine the occurrence of acute
illness. Specimens were collected for viral isolation from
persons reporting respiratory symptoms within 2 days of
onset; standard methods for viral propagation and identi-
fication were used.13 Blood-samples were obtained at
recruitment, and again 6 and 12 months thereafter. Before
the 1968-69 Hong Kong influenza outbreak, specific
vaccine had been administered to school-age children as
part of a community trial. 14 Adults had not been inoculated
and the vaccine was not generally available at the time.
Therefore this present report gives data from the two
hundred and seventy-four adults whose serum samples
spanned the outbreak.
Antibody Determinations
The standard hxmagglutination-inhibition test (H.I.) was
performed in microtitre plates using chicken erythrocytes
and four units of antigen; the virus used was A/Aichi/2/68
(H3N2), which contained the H3 hxmagglutinin of Hong
Kong influenza and the N3 neuraminidase present in
Asian and Hong Kong strains. A.N. antibodies were deter-
mined by a micro-modification of the neuraminidase-
dependent haemagglutinin-inhibition test (N.-H.I.) using
1/60 goat anti-human IgG serum to enhance the pattern
of inhibition.15 The antigen used (4 units) was the re-
combinant virus X 15-HK, which contained an equine
influenza hasmagglutinin (H equi1) and the neuraminidase
of Hong Kong influenza (N2). Since man does not have an
antibody against this equine heemagglutinin,3 the antibody
measured in the N.-H.I. test is directed exclusively against
the N2 neuraminidase of recent A strains. For both H.I. and
N.-H.l. tests, sera were treated with Vibrio cholerae receptor-
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destroying enzyme, heated at 56’C for a half-hour and
titrated from an initial dilution of 1/8. A change in antibody
titre was judged to be significant when antibody appeared in
the post-epidemic serum at 1/16 after being absent in the
pre-epidemic serum, or if there was a fourfold rise in anti-
body titre. For the N.-H.I. test only, the presence of a
definite cell button in the first cup, which did not form a
" tear-drop " when plates were tilted, was scored as a
" trace " of A.N. antibody (reciprocal titre 8 [trace]). This
method used in scoring end-points was confirmed by
testing 48 of the sera for antibodies by a chemical neur-
amidase-inhibition (N.I.) technique (with fetuin substrate),
similar to that adopted by the Influenza Centre for the
Americas. 16 Sera with a titre of < 8 in the N.-H.I. test had
a titre of < 5 in the chemical test, whereas sera that had
been scored at 8 (trace) in the N.-H.I. test were found to
have a mean titre of 5 in the chemical test.
Results
Protection Against Influenza Infection
The Hong Kong variant of influenza was first iso-
lated from a specimen collected in the Tecumseh area
on Nov. 17, 1968. The virus continued to be isolated
through the week of Jan. 19, 1969, for a period of 10
weeks. Illness-rates were increased for a 6-week
period extending from the week of Nov. 24 to the week
of Dec. 29. Blood-samples were obtained routinely
from all persons in the study, so that specimens had
been collected before the appearance of the Hong Kong
influenza variant, and others had been collected from
the same individuals after the outbreak. Pairs of
serum-samples spanning the outbreak had been col-
lected from two hundred and seventy-four adults, age
20-45 years. The first serum of the pair was initially
tested by N.-H.I. to determine the frequency of A.N.
antibody before the appearance of Hong Kong
influenza. In a hundred and fifty-nine sera (58%)
no antibody was detected at 1/8 dilution. Fifty-six
sera (20-4%) had a trace of A.N. antibody at that
titre. Antibody at 1/8 titre was exhibited by 35
(12-8%), and antibody at 1/16 or greater was found in
24 (8-8%) of the sera.
This pre-existing antibody to Hong Kong influenza
neuraminidase was a consequence of infection or
vaccination with earlier Asian influenza virus strains,
whose neuraminidases were of the same antigenic
subtype (N2) as the neuraminidases of Hong Kong
influenza.10,11 In contrast, the haemagglutinins of the
Asian influenza viruses were of a subtype (H2) dis-
tinct from that of the Hong Kong influenza hxmag-
glutinin (H3).lO,ll Thus, the specific effects of pre-
epidemic A.N. antibodies on infection with Hong Kong
influenza could be determined under circumstances
TABLE I-RELATION OF PRE-OUTBREAK A.N. ANTIBODY TO INFECTIONS
DURING 1968-69 HONG KONG INFLUENZA OUTBREAK
* Trace of antibody at 1/8 by N.-H.i.
t Infections determined by rise in H.I. antibody titre.
TABLE II-RELATION OF PRE-OUTBREAK A.N. ANTIBODY TO RE-
SPIRATORY ILLNESS, WITH AND WITHOUT EVIDENCE OF INFLUENZA
INFECTION, DURING 10-WEEK INFLUENZA OUTBREAK
* Hong Kong influenza infection determined by rise in H.I. antibody titre.
Number with illness per number in group.
where no effect could be attributed to the possession
of antibodies to hwmagglutinin. 17
To detect these infections, pre and post epidemic
sera from the two hundred and seventy-four individuals
were tested by N.-H.i. and the standard H.I. method.
In no case was there a significant increase in A.N.
antibody without a concomitant increase in H.i. titre.
However, 38% of persons with rise in H.I. titre did not
have a simultaneous increase in A.N. antibody titre.
The total number of infections determined sero-
logically was detected by H.I. (table I) and was classi-
fied according to the A.N. antibody titre present in the
pre-epidemic serum. Individuals who had pre-
epidemic neuraminidase antibodies in their sera had a
lower rate of influenza infection than those without
pre-epidemic A.N. antibody. The proportion of
individuals infected fell steadily as pre-epidemic
A.N. antibody levels rose, and this regression was
statistically significant ( = 5 -09, p < 0 -05). Therefore,
the pre-existing neuraminidase antibody appeared
capable of reducing the frequency of infection with
Hong Kong influenza in the 1968-69 epidemic.
Effect of Neuraminidase Antibodies on Illness
Pre-existing A.N. antibody may modify clinical
expression of influenza infection resulting from
artificial challenge in volunteers. Influenza virus had
been isolated during a 10-week period in Tecumseh.
During this time, weekly records of acute respiratory
illness were obtained by means of telephone calls
or house visits. Several other respiratory agents
circulated in the community at that time, and illnesses
of non-influenzal aaiology must have occurred 11;
the frequency of these illnesses should have been the
same in individuals with comparable influenza A.N.
antibodies. Thus, any differences in illness-rates
would be related to influenza.
For individuals with no detectable pre-outbreak
A.N. antibody, respiratory illness was much more com-
mon among those infected with influenza than among
those who were not (=15-23, p<O’OOS) (table n);
this finding indicates that influenza infections were
most commonly expressed as clinical illness in those
with no pre-existing A.N. antibody. There was a
difference in illness frequency among persons with a
trace of A.N. antibody at 1/8 (=5-39, p<0’05),
but in persons with A.N. antibody levels of 1/8 or
greater the difference had disappeared (/=010,
p>0-05). No other differences in the illness-rates
shown in table 11 were statistically significant. A
similar reduction in illness frequency as A.N. anti-
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body titre increased was found when only respiratory
illnesses with fever were considered, or when the
6-week period of peak influenza prevalence was
examined. These findings, therefore, indicate that
influenza infections were less commonly expressed as
clinical illness when A.N. antibody was present than
when it was absent.
Discussion
In laboratory studies A.N. did not neutralise in-
fluenza virus directly, as did hxmagglutinin antibody,
but it dampened infection by limiting viral spread from
affected to adjacent cells. 6,7 There is an association
between A.N. antibody and protection against influenza
in vivo. Chickens vaccinated with neuraminidase
antigens were protected from lethal challenge with
homologous influenza viruses, but not as effectively
as when haemagglutinin was used as antigen.9 9 Pre-
viously, mice had similarly been protected by active
immunisation, and also by passive transfer of A.N.
antibody." 8 The latter observation demonstrated that
the antibody itself, and not cell-mediated immunity,
was responsible.
In man, determination of the protective role of
A.N. antibody has been complicated by the problem
of differentiating between effects of haemagglutinin
and A.N. antibodies in persons who may have naturally
acquired both. Discriminate analysis of the variables
in a study conducted in persons with haemagglutinin
and A.N. antibodies against the antigens of the chal-
lenge strain disclosed that the A.N. antibody was of
greatest importance in protection. 5 Participants in
another study were preselected for absence of Hg
antibodies.4 Upon challenge of the twenty-one volun-
teers by a laboratory-propagated Hong Kong (HaN2)
virus, no protection from infection could be demon-
strated. However, various degrees of illness severity
were identified, which were significantly related to the
amount of pre-challenge A.N. antibody.
In the present study, the possible effect of hxmag-
glutinin was eliminated because the initial sera were
obtained before virus with the new H, haemagglutinin
had appeared in the Tecumseh area. The effect of
A.N. antibodies was studied for the first time with a
natural virus challenge; the population was large, ran-
domly selected, and was observed to determine the con-
sequences of the outbreak. The decrease in infection-
rates observed with increasing levels of pre-existing
A.N. antibody is convincing evidence that A.N. antibody
can protect against epidemic influenza. Suppression of
clinical expression of the infection agreed with this
finding. In those cases in which the antibody does not
prevent infection it may make it inapparent.
The present data do not permit any estimate of the
relative protective effect of A.N. or hsemagglutinin
antibodies in man, since the study was designed to
examine the independent effect of A.N. However,
there are several indications that neuraminidase is a
relatively poor immunogen. Outbreaks of Asian
influenza had been reported in Tecumseh during the
10 years before the appearance of Hong Kong in-
fluenza in 1968. Yet only 420,, of the adults tested
had detectable titres of A.N. antibodies, mostly at low
levels. In the Hong Kong outbreak, rises in A.N.
antibody titre were not as common as, and never
occurred independently of, rises in H.I. antibody titre.
Repeated exposures to neuraminidase may be neces-
sary before detectable levels of A.N. antibody are
achieved by infection or vaccination.1B-21 The
apparently poor immunogenicity of neuraminidase
may result from its being only a minor component of
the naturally isolated influenza viruses.22-24 Through
genetic manipulation, the amount of neuraminidase
in the virus may be increased. 25 Preparation of such
virus strains and their incorporation into vaccines
should usefully improve A.N. antibody response.
Our present results indicate the advisability of
eliciting A.N. and hsemagglutinin antibodies by vac-
cination to ensure maximum protection against in-
fluenza. In addition to the potential additive or
synergistic effect in protection, there is another ad-
vantage which may be realised, based on the genetic
independence of the two surface antigens. Major
shifts in hsemagglutinin without accompanying major
changes in neuraminidase occurred not only in 1968
but possibly also in 1947 and 1933.11 Development
of vaccines with sufficient potency to maintain high
levels of A.N. antibody in the population would
improve prospects for moderating epidemic influenza
if a similar antigenic event should occur in the future.
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